Table 1:
Switch from EFV+FTC/TDF to: | ||||
---|---|---|---|---|
EVG/c/FTC/TDF (n=10) |
RAL+FTC/TDF (n=10) |
p-value | All participants (n=20) |
|
No. of participants | 10.0 | 10.0 | - | 20.0 |
Age (mean) | 46.5 (9.0) | 47.9 (9.9) | 0.7 | 47.2 (9.2) |
Male gender (%) | 90 | 60 | - | 75 |
CD4 T cell (mean) | 657 (187) | 709 (280.5) | 0.6 | 683 (234) |
HIV-1 RNA <20 copies/ml (%) | 80.0 | 80.0 | - | 80.0 |
On ART (%) | 100 | 100 | - | 100 |
Creatinine (mean) | 0.9 (0.2) | 0.8 (0.2) | 0.4 | 0.9 (0.2) |
Cholesterol (mean) | 178.8 (24.2) | 200.9 (37.0) | 0.1 | 190.0 (32.5) |
% on statin | 10 | 30 | - | 20 |
ALT (mean) | 26.2 (15.2) | 28.6 (15.1) | 0.6 | 27.4 (14.8) |
EFV plasma conc (mcg/ml)* | 2.3 (0.9) | 3.9 (2.3) | 0.1 | 3.1 (1.9) |
8-OH EFV conc | 0.6 (0.4) | 0.5 (0.4) | 0.8 | 0.5 (0.4) |
7-OH EFV conc | 0 (0) | 0.01 (0.01) | 0.1 | 0.01 (0.01) |
Post- EFV plasma conc (mcg/ml) | 0.02 (0.05) | 0 (0) | 0.4 | 0.4 (0.7) |
Post 8-OH EFV conc | 0 (0) | 0 (0) | 0.3 | 0 (0) |
Post 7-OH EFV conc | 0 (0) | 0.01 (0.01) | 0.05 | 0 (0) |
mean (stdv)